期刊
MOLECULAR CARCINOGENESIS
卷 53, 期 7, 页码 505-513出版社
WILEY
DOI: 10.1002/mc.21998
关键词
sodium butyrate; adriamycin; telomerase; hTERT; ovarian cancer
资金
- National Natural Science Foundation of China [81000546, 31000572, 81272834]
- Natural Science Foundation of Liaoning Province [201102273]
- Scientific Research Foundation for Doctoral Program of Liaoning Province of China [20101148]
- New Teacher Fund for Doctor Station by Ministry of Education of China [20102104120013]
- Research Foundation of Shenyang City Science and Technology Bureau [F12-277-1-20]
Activation of telomerase is a key element in oncogenesis and resistance to apoptosis for many cancers. Some histone deacetylase inhibitors (HDACi) or chemotheraputic agents have been reported to downregulate the expression of human telomerase reverse transcriptase (hTERT). However, whether hTERT is involved in cell death of uterine cancer cells induced by combination of HDACi with chemotheraputic regents remain unknown. The present study shows that combining sodium butyrate (NaBu) and adriamycin (ADR) inhibits proliferation of uterine cancer cell lines in a concentration and time-dependent manner. Growth inhibition was accompanied by caspase-dependent apoptosis with reduced telomerase activity and decreased hTERT mRNA expression. Ectopic wild type (WT)-hTERT suppressed the apoptosis induced by NaBu/ADR treatment, while knockdown of hTERT sensitized uterine cancer cells to ADR. Moreover, the addition of NaBu significantly enhanced ADR cytotoxicity for the primary uterine cancer cells with high hTERT expression. These data indicate that downregulation of hTERT is an important part of the mechanism by which NaBu enhances ADR-induced apoptosis, and suggests that combining NaBu and ADR may be effective in treating uterine tumor with high telomerase activity. (C) 2013 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据